GILD Exercise Disclosure
O'day Daniel Patrick · SEC Form 4 · Filed Nov 2, 2026
Exercise
Calculated transaction value
$0
O'day Daniel Patrick Chairman & CEO
GILD
Gilead Sciences Inc
GILD
Transaction date
Oct 30, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 3 days later
GILD daily price context
Close on/before transaction
$170.68
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-qualified Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 15,881 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001638643-26-000038
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$6.48M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gilead Sciences, Inc. GILD | Sale | Nov 2, 2026 | $267.84K |
| Gilead Sciences, Inc. GILD | Sale | Nov 2, 2026 | $322.3K |
| Gilead Sciences, Inc. GILD | Sale | Nov 2, 2026 | $1.33M |
| Gilead Sciences, Inc. GILD | Sale | Nov 2, 2026 | $285.77K |
| Gilead Sciences, Inc. GILD | Sale | Nov 2, 2026 | $342.13K |
| Gilead Sciences, Inc. GILD | Exercise | Oct 30, 2026 | $1.15M |
| Gilead Sciences, Inc. GILD Current | Exercise | Oct 30, 2026 | $0 |
| Gilead Sciences, Inc. GILD | Sale | Oct 30, 2026 | $2.78M |